CR2 and eye neoplasm: In another choroidal neovascularization (CNV) study, antibody blocking of the alternative complement pathway with the fusion protein CR2-fH, combining the iC3b/C3d-binding region of CR2 and the N-terminus of the regulatory CFH, normalized anaphylatoxin levels, and reduced lesion size.48